Today is a great day for all of us. The licensing of the ChAdOx vaccine will mean a step change in vaccine deployment and is one of the most significant developments of the year. As is widely known, the vaccine developed is cheap, easy to store and we have enough doses to meaningfully start talking about widespread programmes of vaccination.
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in